Thus, AEG-1 promotes NASH by the translational upregulation of enzymes of de novo lipogenesis, the inhibition of PPARα-mediated FA β-oxidation and the stimulation of inflammation by activating NF-κB. Here, MTDH is linked to metabolic dysfunction-associated steatohepatitis.